mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |